Compare
CME vs Nasdaq (CME vs NDAQ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year CME (CME) returned +14.1% and Nasdaq (NDAQ) +25.2%; so far this year the figures are +12.0% and +10.3%.
CME is the larger company by market value, about 1.8 times the size of Nasdaq.
On trailing earnings, CME trades at 25.1 times and NDAQ at 29.3 times.
Revenue grew +9.0% at CME and +11.5% at NDAQ over the last year.
CME yields 3.69%. NDAQ yields 1.08%.
Data as of the latest close. Not investment advice.
Relative performance
| CME | NDAQ | |
|---|---|---|
| Price | $305.89 | $107.12 |
| 1-day | -0.44% | +0.27% |
| YTD | +12.01% | +10.29% |
| 1 year | +14.14% | +25.20% |
| 3 years | +45.03% | +119.91% |
| Market cap | $109.7B | $59.5B |
| P/E | 25.1 | 29.3 |
| P/S | 15.73 | 6.50 |
| P/B | 4.13 | 4.95 |
| Revenue growth | +9.00% | +11.50% |
| EPS growth | +18.10% | +30.70% |
| Gross margin % | — | 63.2 |
| Net margin % | 63.5 | 22.8 |
| ROE % | 16.7 | 17.4 |
| Debt / equity | 0.00 | 0.73 |
| FCF yield % | 3.9 | 3.8 |
| Dividend yield % | 3.69 | 1.08 |
| Beta | -0.31 | 0.59 |
| RSI (14) | 64.1 | 66.0 |
| Technical rating |